share_log

Icosavax Insiders Forfeit On 41% Gains After Selling Stock

Icosavax Insiders Forfeit On 41% Gains After Selling Stock

Icosavax 内部人士在卖出股票后没收了 41% 的涨幅
Simply Wall St ·  2023/11/16 05:01

While Icosavax, Inc. (NASDAQ:ICVX) shareholders have had a good week with the stock up 41%, insiders can't say the same having sold stock over the past year. The value of their investment would have been higher had they waited to sell their stock.

尽管Icosavax, Inc.(纳斯达克股票代码:ICVX)股东度过了愉快的一周,该股上涨了41%,但内部人士在过去一年中出售股票却不能说同样的话。如果他们等着卖出股票,他们的投资价值本来会更高。

While insider transactions are not the most important thing when it comes to long-term investing, we would consider it foolish to ignore insider transactions altogether.

尽管在长期投资中,内幕交易并不是最重要的事情,但我们认为完全忽视内幕交易是愚蠢的。

See our latest analysis for Icosavax

查看我们对 Icosavax 的最新分析

Icosavax Insider Transactions Over The Last Year

过去一年的Icosavax内幕交易

Over the last year, we can see that the biggest insider sale was by the insider, Douglas Holtzman, for US$219k worth of shares, at about US$11.14 per share. We generally don't like to see insider selling, but the lower the sale price, the more it concerns us. The silver lining is that this sell-down took place above the latest price (US$9.30). So it may not tell us anything about how insiders feel about the current share price. Douglas Holtzman was the only individual insider to sell over the last year.

在过去的一年中,我们可以看到,最大的内幕交易是内部人士道格拉斯·霍尔兹曼以价值21.9万美元的股票出售,每股约为11.14美元。我们通常不喜欢看到内幕抛售,但是销售价格越低,我们就越担心。一线希望是,此次抛售高于最新价格(9.30美元)。因此,它可能无法告诉我们内部人士对当前股价的看法。道格拉斯·霍尔兹曼是去年唯一一位卖出的个人内部人士。

The chart below shows insider transactions (by companies and individuals) over the last year. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

下图显示了去年的内幕交易(公司和个人)。如果你想确切地知道谁卖了,卖了多少钱,什么时候卖了,只需点击下面的图表即可!

insider-trading-volume
NasdaqGS:ICVX Insider Trading Volume November 16th 2023
纳斯达克证券交易所:ICVX 内幕交易量 2023 年 11 月 16 日

For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket.

对于那些喜欢寻找中奖投资的人来说,这份最近有内幕收购的成长型公司的免费名单可能只是门票。

Insider Ownership Of Icosavax

Icosavax 的内部所有权

Looking at the total insider shareholdings in a company can help to inform your view of whether they are well aligned with common shareholders. A high insider ownership often makes company leadership more mindful of shareholder interests. Insiders own 3.4% of Icosavax shares, worth about US$16m. While this is a strong but not outstanding level of insider ownership, it's enough to indicate some alignment between management and smaller shareholders.

查看公司的内部人持股总额可以帮助您了解他们是否与普通股股东保持良好关系。较高的内部人所有权通常会使公司领导层更加关注股东的利益。业内人士拥有Icosavax3.4%的股份,价值约1600万美元。尽管这是内部人所有权强劲但并不突出的水平,但这足以表明管理层与小股东之间有一定的一致性。

What Might The Insider Transactions At Icosavax Tell Us?

Icosavax 的内幕交易会告诉我们什么?

There haven't been any insider transactions in the last three months -- that doesn't mean much. Still, the insider transactions at Icosavax in the last 12 months are not very heartening. But it's good to see that insiders own shares in the company. In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Icosavax. When we did our research, we found 4 warning signs for Icosavax (1 is concerning!) that we believe deserve your full attention.

在过去的三个月中,没有任何内幕交易——这并不意味着什么。尽管如此,在过去的12个月中,Icosavax的内幕交易并不令人振奋。但很高兴看到内部人士拥有该公司的股份。除了了解正在进行的内幕交易外,识别Icosavax面临的风险也是有益的。当我们进行研究时,我们发现了 Icosavax 的 4 个警告信号(1 个令人担忧!)我们认为值得你充分关注。

Of course Icosavax may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

当然,Icosavax可能不是最值得买入的股票。因此,您可能希望看到这些免费的高质量公司集。

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

就本文而言,内部人士是指向相关监管机构报告其交易的个人。我们目前只考虑公开市场交易和私下处置的直接利益,不包括衍生品交易或间接权益。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧?直接联系我们。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发